There is a newer version
of
this Chapter
2020 Indiana Code
Title 12. Human Services
Article 15. Medicaid
Chapter 35. Drug Utilization Review
- 12-15-35-1. "Appropriate and Medically Necessary" Defined
- 12-15-35-2. "Board" Defined
- 12-15-35-3. "Compendia" Defined
- 12-15-35-4. "Counseling" Defined
- 12-15-35-4.5. "Covered Outpatient Drug" Defined
- 12-15-35-5. "Criteria" Defined
- 12-15-35-6. "Drug-Disease Contraindication" Defined
- 12-15-35-7. "Drug-Drug Interaction" Defined
- 12-15-35-8. "Drug Utilization Review" or "Dur" Defined
- 12-15-35-9. "Intervention" Defined
- 12-15-35-10. "Overutilization or Underutilization" Defined
- 12-15-35-11. "Pharmacist" Defined
- 12-15-35-12. "Physician" Defined
- 12-15-35-13. "Prospective Dur" Defined
- 12-15-35-14. "Retrospective Dur" Defined
- 12-15-35-15. "Standards" Defined
- 12-15-35-16. "Surs" Defined
- 12-15-35-17. "Therapeutic Appropriateness" Defined
- 12-15-35-17.5. "Therapeutic Classification" or "Therapeutic Category" Defined
- 12-15-35-18. "Therapeutic Duplication" Defined
- 12-15-35-18.5. Application of Chapter
- 12-15-35-18.7. Formulary Requirements
- 12-15-35-19. Drug Utilization Review Board; Establishment
- 12-15-35-20. Membership of Board
- 12-15-35-20.1. Conflicts of Interest
- 12-15-35-20.5. Therapeutics Committee Established; Members; Limitations; Terms; Votes; Meetings
- 12-15-35-21. Board; Appointment; Term
- 12-15-35-22. Qualifications of Board Members
- 12-15-35-23. Physician Appointments; Geographic Balance
- 12-15-35-24. Reappointment of Members
- 12-15-35-25. Chairman; Compensation; Expenses
- 12-15-35-26. Additional Staff
- 12-15-35-27. Retrospective and Prospective Dur Program Responsibility
- 12-15-35-28. Duties of the Board; Preferred Drug List; Report
- 12-15-35-28.5. Therapeutics Committee Duties
- 12-15-35-28.7. Submitting Initial Preferred Drug List; Limitations on Restrictions; Advance Notice to Providers; Implementation; Prior Authorization Limitation; Rules
- 12-15-35-29. Quorum; Majority Vote on Dur Criteria and Standards for Prescribing
- 12-15-35-30. Local Practices; Monitoring
- 12-15-35-31. Intervention; Approval; Requisites
- 12-15-35-32. Repealed
- 12-15-35-32.1. Annual Report Contents
- 12-15-35-33. Repealed
- 12-15-35-34. Confidential Identifying Information; Release of Cumulative Nonidentifying Information
- 12-15-35-35. Prior Approval Program for Outpatient Drugs; Standards
- 12-15-35-36. Advisory Committees
- 12-15-35-37. Medicaid State Plan; Inclusion of Retrospective and Prospective Dur Program
- 12-15-35-38. Dur Program Guidelines and Procedures
- 12-15-35-39. Retrospective Dur Requisites
- 12-15-35-40. Prospective Dur Requisites
- 12-15-35-41. Board Activities Under Ic 34-30-15
- 12-15-35-42. Meetings
- 12-15-35-43. Confidentiality; Pharmacist Data and Information
- 12-15-35-43.5. Prohibiting the Release of Proprietary or Confidential Information Obtained Under Certain Circumstances
- 12-15-35-44. Confidentiality; Violations; Penalty
- 12-15-35-45. Outpatient Drug Formulary; Requirements
- 12-15-35-46. Review of Proposed Formulary
- 12-15-35-47. Review of Changes to Formulary
- 12-15-35-48. Board Review of Managed Care Organization Prescription Drug Program
- 12-15-35-49. Information Provided by Office
- 12-15-35-50. Maximum Allowable Cost Schedule for Drugs; Pharmacy Participation in Medicaid Program
- 12-15-35-51. Advisory Committee; Duties; Report
Disclaimer: These codes may not be the most recent version. Indiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.